Alessandro Pulsoni

Latina, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 111 publications

Survival after first relapse in marginal zone lymphomas: Prospective data from the international observational NF10 study.

Survival after first relapse in marginal zone lymphomas: Prospective data from the international observational NF10 study.

Journal: British journal of haematology

Published: May 16, 2026

Short BRAF+MEK coinhibition, alone and combined with anti-CD20 immunotherapy, in relapsed or refractory hairy cell leukemia: An investigator-sponsored multi-center phase 2 clinical trial.

Short BRAF+MEK coinhibition, alone and combined with anti-CD20 immunotherapy, in relapsed or refractory hairy cell leukemia: An investigator-sponsored multi-center phase 2 clinical trial.

Journal: HemaSphere

Published: April 30, 2026

Direct-Acting Antiviral Agents in Hepatitis C-Associated Indolent Lymphomas.

Direct-Acting Antiviral Agents in Hepatitis C-Associated Indolent Lymphomas.

Journal: The New England journal of medicine

Published: December 30, 2025

Hepatitis C virus and hepatitis B virus in indolent lymphomas: Prospective data from the international observational NF10 study.

Hepatitis C virus and hepatitis B virus in indolent lymphomas: Prospective data from the international observational NF10 study.

Journal: British journal of haematology

Published: November 22, 2025

Prognostic impact of treatment-related and geriatric factors in older patients with classic Hodgkin lymphoma: A real-life cohort study.

Prognostic impact of treatment-related and geriatric factors in older patients with classic Hodgkin lymphoma: A real-life cohort study.

Journal: British journal of haematology

Published: November 16, 2025

Real-life efficacy and safety of vemurafenib plus rituximab in relapsed or refractory hairy-cell leukemia: A multicenter Italian retrospective study (HCL-PG03R).

Real-life efficacy and safety of vemurafenib plus rituximab in relapsed or refractory hairy-cell leukemia: A multicenter Italian retrospective study (HCL-PG03R).

Journal: HemaSphere

Published: September 08, 2025

Intermediate doses cytarabine after induction with CPX-351 for patients with secondary AML: safety and efficacy.

Intermediate doses cytarabine after induction with CPX-351 for patients with secondary AML: safety and efficacy.

Journal: Annals of hematology

Published: August 30, 2025

Outpatient Versus Inpatient Azacitidine Plus Venetoclax Regimen in Elderly Acute Myeloid Leukemia: A Multicenter Retrospective Analysis.

Outpatient Versus Inpatient Azacitidine Plus Venetoclax Regimen in Elderly Acute Myeloid Leukemia: A Multicenter Retrospective Analysis.

Journal: European journal of haematology

Published: July 23, 2025

Asciminib and pulsed ATRA as post-remission therapy in T315I mutated PML-RARA-positive blast crisis of chronic myeloid leukemia.

Asciminib and pulsed ATRA as post-remission therapy in T315I mutated PML-RARA-positive blast crisis of chronic myeloid leukemia.

Journal: Annals of hematology

Published: May 11, 2025

Luspatercept in lower-myelodysplastic syndromes (MDS): Real-world data from the Gruppo Romano-Laziale Mielodisplasie (GROM-L) and review of literature.

Luspatercept in lower-myelodysplastic syndromes (MDS): Real-world data from the Gruppo Romano-Laziale Mielodisplasie (GROM-L) and review of literature.

Journal: Leukemia research

Published: March 09, 2025

A Case of Multiple Myeloma in a Patient in Treatment for Chronic Lymphocytic Leukemia.

A Case of Multiple Myeloma in a Patient in Treatment for Chronic Lymphocytic Leukemia.

Journal: Mediterranean journal of hematology and infectious diseases

Published: February 18, 2025

Monoclonal Gammopathy of Neurological Significance: A Case Report and Insights on Treatment.

Monoclonal Gammopathy of Neurological Significance: A Case Report and Insights on Treatment.

Journal: Mediterranean journal of hematology and infectious diseases

Published: February 18, 2025

Showing 1-12 of 111

Last Updated: 09/26/2026